MedTrace Logo

Patient Blood Management In CARdiac sUrgical patientS

NCT04744181 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 479

Last updated 2025-08-14

No results posted yet for this study

Summary

Nowadays up to 40% of patients undergoing cardiac surgery receives at least 1 unit of red blood cell transfusion during surgery or during the first week after surgery. Moreover up to 40% of these patients shows an absolute or relative iron deficiency, with or without anaemia.

The objective of this study is to assess whether to implement an adequate correction of iron according to current "patients blood management" recommendations might reduce RBC transfusion requirements in patients undergoing heart surgery.

Data obtained in patients included in the study will be compared to those of a case-control population selected from patients consecutively treated at the same department in the previous 2 years.

Conditions

Interventions

DRUG

Ferric carboxymaltose

administration of a single dose of ferric carboxymaltose in those patietns who fulfill the inclusion criteria

DRUG

B vitamin

administration of a single dose of B vitamin in those patietns who fulfill the inclusion criteria

DRUG

Folic acid

administration of a single dose of folic acid in those patietns who fulfill the inclusion criteria

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • filippo corsi, Dr · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2022-01-01
Completion
2022-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04744181 on ClinicalTrials.gov